Surgical Mesh Instruments Classification Will Be One Focus Of February Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA will hold an advisory panel meeting on urogynecological surgical mesh instrumentation on Feb. 26. The focus of the meeting will be whether to up-classify the devices from class I to class II with special controls, including a new 510(k) requirement.
You may also be interested in...
PMA Mandate Set For Pelvic Organ Prolapse Transvaginal Mesh
FDA issued final orders up-classifying surgical mesh for transvaginal repair of pelvic organ prolapse from class II to class III and calling for PMA standards, including clinical trial, animal studies, and materials testing data from new and existing manufacturers.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.